Novo CEO Mike Doustdar discusses investor confidence, drug testing and the potential for expanding the firm's obesity offerings. "We should also have a mindset that we don't have a patent or a monopoly on all the good ideas," Doustdar tells Bloomberg Television. "When there is a gap, strategica...
Source: [Bloomberg Markets](https://www.bloomberg.com/news/videos/2026-09-22/novo-still-has-work-to-do-to-build-confidence-ceo-says-video)